Second, we found that gefitinib was effective in reducing pulmonary fibrosis in mice, which might be associated with the HMGB1/NOXs-ROS/EGFR-MAPKs-AP-1/NF-κB signal (Figure 10). This evidence concerns the gene NFKB1 and pulmonary fibrosis.